Authors
Loading...
This review highlights therapeutic approaches for chronic kidney disease, emphasizing advances in RAAS blockade and SGLT2 inhibitors.
Doumani et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: